ATRX and central nervous system cancer: Rpp29-ko was associated with an increased MYCN expression [37], and N-Myc overexpression was utilized by Funato et al. to create a graftable G3.3-G34R mutant glioma model harboring ATRX-ko and TP53-ko mutations [44].